Pancreatic Cancer Research

ResearcherMedical University of BiałystokActive in the last 2 years

A Dâbrowski

Matched on ORCID iD 0000-0002-5996-394X; OpenAlex author ID A5033495524. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. The development of pancreatic cancer is accompanied by significant changes in the immune response in genetically predisposed mice. Last author DOI 10.3389/fonc.2025.1603293↗
  2. Microbiome-Friend or Foe of Pancreatic Cancer? Co-author DOI 10.3390/jcm10235624↗
  3. Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club. Co-author DOI 10.5114/pg.2019.83422↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Agnieszka Katarzyna Swidnicka-Siergiejko · 2 shared papers, 2021–2025 · strength 0.44
  2. Jarosław Daniluk · 2 shared papers, 2021–2025 · strength 0.44
  3. Urszula Daniluk · 2 shared papers, 2021–2025 · strength 0.44
  4. Katarzyna Guzińska-Ustymowicz · 1 shared paper, 2025 · strength 0.27
  5. Anna Pryczynicz · 1 shared paper, 2025 · strength 0.27
  6. Katarzyna Winter · 1 shared paper, 2019 · strength 0.08
  7. Stanisław Głuszek · 1 shared paper, 2019 · strength 0.08
  8. Anita Gąsiorowska · 1 shared paper, 2019 · strength 0.08
  9. Marek Durlik · 1 shared paper, 2019 · strength 0.08
  10. Janusz Strzelczyk · 1 shared paper, 2019 · strength 0.08
  11. Renata Talar‐Wojnarowska · 1 shared paper, 2019 · strength 0.08
  12. Paweł Lampe · 1 shared paper, 2019 · strength 0.08
  13. Ewa I. Malecka-Panas · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.